NewsRx

Search our medical news database

Allergies

Perot Systems Expands Its Long-time Relationship With National Institute of Allergy and Infectious Diseases

Published in Immunotherapy Weekly, April 18th, 2007

Perot Systems Corporation (NYSE:PER) announced that its government subsidiary won a contract to support the National Institute of Allergy and Infectious Diseases (NIAID) for support of its application and infrastructure services in the United States, Africa and South Asia. GovWorks, Department of the Interior's Federal Acquisition Center, awarded the contract on behalf of NIAID, and confirms the value of this agreement not to exceed $145 million dollars.

Perot Systems has provided technical support to this customer since 1994 and today has more than 130 associates dedicated to implementing infrastructure services to support the expanding program. Under the new...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Immunotherapy Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook